Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI.

Abstract:

PURPOSE:To quantify needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer and propose a threshold for needle migration. METHODS AND MATERIALS:Twenty-four high-risk prostate cancer patients treated with an HDR boost of 2 × 8.5 Gy were included. Patients received an MRI for planning (MRI1), before (MRI2), and after treatment (MRI3). Time from needle insertion to MRI3 was ∼3 hours. Needle migration was evaluated from coregistered images: MRI1-MRI2 and MRI1-MRI3. Dose volume histogram parameters from the treatment plan based on MRI1 were related to parameters based on needle positions in MRI2 or MRI3. Regression was used to model the average needle migration per implant and change in D90 clinical target volume, CTVprostate+3mm. The model fit was used for estimating the dosimetric impact in equivalent dose in 2 Gy fractions for dose levels of 6, 8.5, 10, 15, and 19 Gy. RESULTS:Needle migration was on average 2.2 ± 1.8 mm SD from MRI1-MRI2 and 5.0 ± 3.0 mm SD from MRI1-MRI3. D90 CTVprostate+3mm was robust toward average needle migration ≤3 mm, whereas for migration >3 mm D90 decreased by 4.5% per mm. A 3 mm of needle migration resulted in a decrease of 0.9, 1.7, 2.3, 4.8, and 7.6 equivalent dose in 2 Gy fractions for dose levels of 6, 8.5, 10, 15, and 19 Gy, respectively. CONCLUSIONS:Substantial needle migration in high-dose-rate brachytherapy occurs frequently in 1-3 hours following needle insertion. A 3-mm threshold of needle migration is proposed, but 2 mm may be considered for dose levels ≥15 Gy.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Buus S,Lizondo M,Hokland S,Rylander S,Pedersen EM,Tanderup K,Bentzen L

doi

10.1016/j.brachy.2017.08.005

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

50-58

issue

1

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(17)30427-0

journal_volume

17

pub_type

杂志文章
  • Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.

    abstract:PURPOSE:To evaluate the efficacy and side effect profile of adjuvant vaginal vault brachytherapy alone after hysterectomy in Stage I endometrial carcinoma. METHODS AND MATERIALS:Between 23/11/1992 and 16/05/2005, a total of 173 patients with early endometrial carcinoma treated with vaginal vault brachytherapy alone po...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2008.01.001

    authors: Chong I,Hoskin PJ

    更新日期:2008-04-01 00:00:00

  • Improving patient-specific dosimetry for intravascular brachytherapy.

    abstract:PURPOSE:Accurate patient-specific dosimetry in intravascular brachytherapy (IVBT) is generally difficult due to the extremely high-dose gradient, complexity of treatment device, and patient-specific geometry (e.g., calcification, stent, curvature, movement of target). The purpose of this study is to analyze quantitativ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2005.07.004

    authors: Li XA,O'Neill M,Suntharalingam M

    更新日期:2005-01-01 00:00:00

  • Income generated by women treated with magnetic resonance imaging-based brachytherapy: A simulation study evaluating the macroeconomic benefits of implementing a high-end technology in a public sector healthcare setting.

    abstract:PURPOSE:To estimate the difference in income generated if all women presenting in our institute over a 5-year period were treated with MRI-based image-guided brachytherapy (MR-IGBT) instead of conventional radiograph-based brachytherapy (CR-BT). METHODS AND MATERIALS:Outcome data from 463 patients (94 treated with MR-...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.05.003

    authors: Chakraborty S,Mahantshetty U,Chopra S,Lewis S,Hande V,Gudi S,Krishnatry R,Engineer R,Shrivastava SK

    更新日期:2017-01-01 00:00:00

  • A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer.

    abstract:PURPOSE:Stereotactic body radiotherapy (SBRT) is being used with increasing frequency as definitive treatment of early stage prostate cancer. Much of the justification for its adoption was derived from earlier clinical results using high-dose-rate (HDR) brachytherapy. We determine whether HDR's dosimetry can be achieve...

    journal_title:Brachytherapy

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.brachy.2013.03.003

    authors: Spratt DE,Scala LM,Folkert M,Voros L,Cohen GN,Happersett L,Katsoulakis E,Zelefsky MJ,Kollmeier MA,Yamada Y

    更新日期:2013-09-01 00:00:00

  • Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.

    abstract:PURPOSE:To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy. METHODS AND MATERIALS:Between 1/1998 and 10/2006, 21 patients with T0 or T1 in-br...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2007.12.001

    authors: Trombetta M,Julian T,Bhandari T,Werts ED,Miften M,Parda D

    更新日期:2008-01-01 00:00:00

  • Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program.

    abstract:PURPOSE:To describe in detail British Columbia (BC) Cancer Agency (BCCA) Provincial Prostate Brachytherapy (PB) Quality Assurance (QA) Program. METHODS AND MATERIALS:The BCCA PB Program was established in 1997. It operates as one system, unified and supported by electronic and information systems, making it a single P...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2012.03.006

    authors: Keyes M,Morris WJ,Spadinger I,Araujo C,Cheung A,Chng N,Crook J,Halperin R,Lapointe V,Miller S,Pai H,Pickles T

    更新日期:2013-07-01 00:00:00

  • Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy.

    abstract:PURPOSE:The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS:Monte Carlo...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2011.11.005

    authors: Vijande J,Ballester F,Ouhib Z,Granero D,Pujades-Claumarchirant MC,Perez-Calatayud J

    更新日期:2012-11-01 00:00:00

  • Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer.

    abstract:PURPOSE:To describe the use of dual source strength implants for focal low-dose-rate brachytherapy. METHODS AND MATERIALS:An interneedle dual source strength planning strategy is described for focal low-dose-rate brachytherapy of the prostate. The implanted treatment plans were designed using peripheral (except near t...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.04.388

    authors: Mahdavi SS,Spadinger IT,Chng NT,Morris WJ

    更新日期:2016-09-01 00:00:00

  • Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.

    abstract:PURPOSE:There is strong evidence relating postimplant dosimetry for low-dose-rate prostate seed brachytherapy to local control rates. The delineation of the prostate on CT images, however, represents a challenge due to the lack of soft-tissue contrast to identify the prostate borders. This study aims at quantifying the...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.08.013

    authors: Mashouf S,Safigholi H,Merino T,Soliman A,Ravi A,Morton G,Song WY

    更新日期:2016-01-01 00:00:00

  • LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.

    abstract:PURPOSE:Permanent LDR brachytherapy and temporary HDR brachytherapy are competitive techniques for clinically localized prostate radiotherapy. Although a randomized trial will likely never be conducted comparing these two forms of brachytherapy, a comparative radiobiological modeling analysis proves useful in understan...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/S1538-4721(02)00101-0

    authors: King CR

    更新日期:2002-01-01 00:00:00

  • Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients.

    abstract:PURPOSE:The aim of this study was to estimate the incidence of complications after (90)Y microsphere radioembolization for unresectable hepatic tumors and evaluate risk factors for late complications. METHODS AND MATERIALS:A cohort of 112 consecutive patients from two institutions underwent (90)Y microsphere radioembo...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2013.05.008

    authors: Peterson JL,Vallow LA,Johnson DW,Heckman MG,Diehl NN,Smith AA,Tzou KS,Paz-Fumagalli R,Kim S,Ko SJ,Daugherty LC,Kim GP,Brown N,Mori KW,Buskirk SJ

    更新日期:2013-11-01 00:00:00

  • Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer.

    abstract:PURPOSE:The aim of this work was to analyze the results of palliative HDR brachytherapy in patients with advanced esophageal cancer. METHODS AND MATERIALS:Ninety-one patients with unresectable, advanced esophageal cancer were treated palliatively by HDR brachytherapy. All patients received a total dose of 22.5 Gy in t...

    journal_title:Brachytherapy

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.brachy.2004.05.003

    authors: Skowronek J,Piotrowski T,Zwierzchowski G

    更新日期:2004-01-01 00:00:00

  • Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.

    abstract:PURPOSE:To evaluate dosimetry and source location relative to CT-based dosimetry when performing real-time dynamic permanent prostate brachytherapy (PPB) with inverse treatment planning. METHODS AND MATERIALS:A treatment algorithm for dynamic PPB was developed using inverse treatment planning. The technique utilizes r...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/S1538-4721(03)00134-X

    authors: Potters L,Calguaru E,Thornton KB,Jackson T,Huang D

    更新日期:2003-01-01 00:00:00

  • Is prostate-specific antigen percentage decrease predictive of clinical outcome after permanent iodine-125 interstitial brachytherapy for prostate cancer?

    abstract:OBJECTIVE:To determine the usefulness of prostate-specific antigen (PSA) percentage (vs. pretreatment value assumed as 100%) in prediction of biochemical relapse, after iodine-125 ((125)I) permanent brachytherapy for prostate cancer, to employ a parameter independent by the initial PSA amount and by the individual pros...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2011.08.008

    authors: Paoluzzi M,Mignogna M,Lorenzini E,Valent F,Fontana N,Pinzi N,Repetti F,Ponchietti R

    更新日期:2012-07-01 00:00:00

  • Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada.

    abstract:PURPOSE:To recognize the practice of radiotherapy for management of cervical cancer in Ontario, Canada, and to use the results of the survey to harmonize and standardize practice across the province. METHODS AND MATERIALS:An electronic survey (SurveyMonkey) was sent to all 14 provincial cancer centers by Cancer Care O...

    journal_title:Brachytherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.brachy.2018.03.003

    authors: Shahid N,Craig T,Westerland M,Ashworth A,Ang M,D'Souza D,Sankreacha R,Fyles A,Milosevic M,Kong I,Cancer Care Ontario Radiation Treatment Gynecologic Oncology Community of Practice.

    更新日期:2018-01-01 00:00:00

  • Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapy.

    abstract:PURPOSE:To identify patients at extremely low risk of biochemical recurrence (BCR) of prostate cancer after low-dose-rate brachytherapy (LDR-BT) to determine when prostate-specific antigen (PSA) monitoring can be stopped. METHODS AND MATERIALS:We retrospectively reviewed clinicopathologic data of patients with prostat...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.08.018

    authors: Niwa N,Matsumoto K,Nishiyama T,Yagi Y,Ozu C,Nakamura K,Saito S,Oya M

    更新日期:2018-01-01 00:00:00

  • A pilot study of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice.

    abstract:PURPOSE:To investigate the safety and feasibility of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice. METHODS AND MATERIALS:From January 2010 to February 2015, 18 consecutive patients diagnosed with locally advanced, nonmetastatic, inope...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.05.004

    authors: Yang M,Yan Z,Luo J,Liu Q,Zhang W,Ma J,Zhang Z,Yu T,Zhao Q,Liu L

    更新日期:2016-01-01 00:00:00

  • The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.

    abstract:PURPOSE:To evaluate the effect of hormonal manipulation on catheter dependency, the resolution of urinary symptomatology, and the need for postbrachytherapy transurethral/transincisional resection (TURP/TUIP). METHODS AND MATERIALS:Seven hundred sixteen consecutive patients (median follow-up, 29 months) underwent brac...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2003.12.001

    authors: Merrick GS,Butler WM,Wallner KE,Murray B,Allen Z,Lief JH,Galbreath RW

    更新日期:2004-01-01 00:00:00

  • Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.

    abstract:PURPOSE:To evaluate the long-term disease control and toxicity to the organs at risk after dose-escalated image-based adaptive brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Sixty patients of cervical cancer were treated with external radiotherapy 46 Gy in 23 fractions with weekly cisplatin and MRI-guide...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.09.008

    authors: Simha V,Rai B,Patel FD,Kapoor R,Sharma SC,Singh OA,Singla V,Dhanireddy B,Ghoshal S

    更新日期:2018-01-01 00:00:00

  • Preclinical study investigating the potential of low-dose-rate brachytherapy with 32P stents for the prevention of restenosis of paranasal neo-ostia.

    abstract:PURPOSE:Ostial restenosis is a common cause of failures in paranasal sinus surgery. The aim of the current study was to investigate the use of low-dose-rate brachytherapy to prevent neo-ostial restenosis in an animal model. METHODS AND MATERIALS:In 14 rabbits, maxillary neo-ostia were created and measured. One side ea...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.08.011

    authors: Oestreicher E,Bartsch H,Mayr D,Schubert M,Weber B,Kneschaurek P,Assmann W,Sroka R,Betz CS

    更新日期:2017-01-01 00:00:00

  • CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.

    abstract:PURPOSE:To evaluate the clinical outcomes of women receiving a "short" course of high-dose-rate gynecologic interstitial brachytherapy (HDR-ISBT) boost with CT-based 3D planning. METHODS AND MATERIALS:Forty-seven women with no prior radiation received HDR-ISBT from August 2004 to February 2012. The mean external beam ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2014.02.001

    authors: D'Souza D,Wiebe E,Patil N,Sugimoto A,Prefontaine M,Aulakh S,Whiston F,Stitt L,Surry K

    更新日期:2014-05-01 00:00:00

  • Online correction of catheter movement using CT in high-dose-rate prostate brachytherapy.

    abstract:PURPOSE:To present a clinical procedure that readjusts catheters to its planned positions based on pretreatment computed tomography (CT) for patients undergoing high-dose-rate (HDR) prostate brachytherapy, and evaluate the magnitude and dosimetric impact of the adjustments. METHODS AND MATERIALS:Patients received a pr...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2012.08.008

    authors: Huang Y,Miller B,Doemer A,Babij D,Kumar S,Frontera R,Nurushev T,Chetty IJ,Aref I

    更新日期:2013-05-01 00:00:00

  • Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.

    abstract:OBJECTIVE:To evaluate the feasibility and intermediate-term results of a short course of high-dose-rate (HDR) intravaginal brachytherapy only after hysterectomy. METHODS AND MATERIALS:From December 1999 to February 2005, 50 patients with International federation of gynecology and obstetrics Stages IA-IIB endometrioid ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2007.04.001

    authors: Martínez-Monge R,Nagore G,Cambeiro M,Garrán C,Villafranca E,Jurado M

    更新日期:2007-07-01 00:00:00

  • A linear source table to determine the treatment times for cylindrical applicators used in high-dose rate brachytherapy.

    abstract:PURPOSE:It is a good practice for quality assurance purposes to check the high-dose rate brachytherapy source dwell times obtained from any computerized treatment planning system (TPS) by independent hand calculations. The aim of this work was to prepare a table that would help to calculate the total dwell times for cy...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2010.08.010

    authors: Sha RL,Reddy PY,Sahoo N

    更新日期:2011-05-01 00:00:00

  • A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy.

    abstract:PURPOSE:To determine whether potential extraprostatic extension (EPE) of prostate adenocarcinoma is covered by the prescribed dose when permanent 125I implants are planned with a 5-mm treatment margin. METHODS AND MATERIALS:The postimplant dosimetry of 60 consecutive 125I prostate implants was analyzed to determine wh...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2003.09.002

    authors: Patel AB,Waterman FM,Dicker AP

    更新日期:2003-01-01 00:00:00

  • CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy.

    abstract:PURPOSE:To evaluate the feasibility, efficacy, and safety of permanent (125)I seed interstitial brachytherapy reirradiation in patients with retroperitoneal lymph node recurrence under CT guidance. METHODS AND MATERIALS:Seventeen patients with 19 retroperitoneal lymph node recurrence after external beam radiotherapy u...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2015.05.008

    authors: Yao L,Jiang Y,Jiang P,Wang H,Meng N,Qu A,Tian S,Sun H,Liu C,Wang J,Zhang K

    更新日期:2015-09-01 00:00:00

  • Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetry.

    abstract:PURPOSE:The study aimed to analyze the Pro-Qura database in terms of patient implant sequence number for each institution to determine evidence for a dosimetric learning curve. METHODS AND MATERIALS:In the Pro-Qura database, 2833 of a total of 4614 postplans from 57 brachytherapists were analyzed for evidence of a dos...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2006.10.002

    authors: Merrick GS,Grimm PD,Sylvester J,Blasko JC,Butler WM,Allen ZA,Chaudhry UU,Mazza A,Sitter M

    更新日期:2007-01-01 00:00:00

  • Localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy.

    abstract:OBJECTIVE:The aim of the study is to compare the results of the combined external beam radiotherapy (EBRT) with iodine-125 seed brachytherapy vs. brachytherapy alone for prostate cancer treatment in patients with intermediate and high risk of disease recurrence. METHODS AND MATERIALS:Ninety-six patients were treated f...

    journal_title:Brachytherapy

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.brachy.2009.07.011

    authors: da Silva Franca CA,Vieira SL,Carvalho AC,Bernabé AJ,Penna AB

    更新日期:2010-10-01 00:00:00

  • Clinical factors and dosimetry associated with the development of prostate brachytherapy-related urethral strictures: A matched case-control study.

    abstract:PURPOSE:Urethral strictures are a rare complication of prostate brachytherapy (BXT), with prior studies showing radiation dose to the bulbomembranous urethra as being associated with stricture formation. This retrospective case-control study explored clinical and dosimetric parameters associated with the development of...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.04.242

    authors: Singhal S,Jamaluddin MF,Lee E,Sloboda RS,Parliament M,Usmani N

    更新日期:2017-01-01 00:00:00

  • Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.

    abstract:PURPOSE:To explore the dosimetric advantage of target volume and surrounding normal tissue by using interstitial (IS) brachytherapy (BT) based on three-dimensional CT in locally advanced cervical cancer, as a simple and effective clinical treatment approach. METHODS AND MATERIALS:Fifty-two patients with poor tumor res...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.06.004

    authors: Liu ZS,Guo J,Lin X,Wang HY,Qiu L,Ren XJ,Li YF,Zhang BY,Wang TJ

    更新日期:2016-09-01 00:00:00